SHELLEY FOGT: Open Payments
NPI 1861856015 · WAPAKONETA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 23 payments from 10 companies in 2025. Trend: 2023 $326 · 2024 $305 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Novo Nordisk Inc | 4 | $70 |
| Lilly USA, LLC | 3 | $66 |
| Exact Sciences Corporation | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: MOUNJARO, Wegovy, VRAYLAR, FARXIGA, AIRSUPRA, QULIPTA, UBRELVY, Ozempic.
Industry payments across OH — which companies pay providers there.
